BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34790368)

  • 1. Preliminary evaluation of postoperative radiotherapy with small T-shaped field in thoracic esophageal squamous cell carcinoma.
    Zhao Q; Zhu J; Liu Y; Qin S; Zhou J
    J Gastrointest Oncol; 2021 Oct; 12(5):2004-2012. PubMed ID: 34790368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial.
    Zhang X; Ai D; Wang J; Chen Y; Liu Q; Deng J; Yang H; Nie Y; Chen W; Zhao W; Zhao K
    Front Oncol; 2021; 11():669575. PubMed ID: 34295813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience.
    Jethwa KR; Day CN; Sandhyavenu H; Gonuguntla K; Harmsen WS; Breen WG; Routman DM; Garda AE; Hubbard JM; Halfdanarson TR; Neben-Wittich MA; Merrell KW; Hallemeier CL; Haddock MG
    Clin Transl Radiat Oncol; 2021 May; 28():17-23. PubMed ID: 33732911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial.
    Li H; Gu D; Du M; Zhou G; Zhang Z; Ye J
    Front Oncol; 2022; 12():900443. PubMed ID: 35847922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma.
    Zhang X; Yang X; Ni J; Li Y; Zou L; Chu L; Chu X; Xia F; Zhu Z
    Radiat Oncol; 2018 Dec; 13(1):255. PubMed ID: 30587211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].
    Wang YX; Yang Q; He M; Qiu R; Li J; Zhu SC; Qiao XY; Qi Z
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):48-55. PubMed ID: 28104034
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary analysis of the benefits of different irradiation types on patients with postoperative locoregional recurrence of esophageal cell squamous carcinoma.
    Gao HM; Shen WB; Zhang XY; Xu JR; Li YM; Li SG; Zhu SC
    Ann Palliat Med; 2021 Sep; 10(9):9467-9479. PubMed ID: 34628872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume.
    Cui T; Zhang H; Yu T; Chen Y; Liu C; Zhao Q; Zhu J; Li B; Huang W
    Front Oncol; 2021; 11():652365. PubMed ID: 33937059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II trial comparing tumor bed alone with tumor bed and elective nodal postoperative radiotherapy in patients with locoregionally advanced thoracic esophageal squamous cell carcinoma.
    Cai XW; Zeng Y; Feng W; Liu MN; Yu W; Zhang Q; Liu J; Wang JM; Lv CX; Fu XL
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30855089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective.
    Kim KH; Chang JS; Cha JH; Lee IJ; Kim DJ; Cho BC; Park KR; Lee CG
    Cancer Res Treat; 2017 Jan; 49(1):168-177. PubMed ID: 27338033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy.
    Liu Q; Cai XW; Wu B; Zhu ZF; Chen HQ; Fu XL
    PLoS One; 2014; 9(5):e97225. PubMed ID: 24820177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma.
    Li L; Zhao L; Lin B; Su H; Su M; Xie D; Jin X; Xie C
    J Cancer; 2017; 8(11):2051-2059. PubMed ID: 28819406
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
    Ren XJ; Wang L; Han C; Liu LL
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
    [No Abstract]   [Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
    Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
    J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IMRT-based preoperative neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma (ESCC): an analysis of outcome and prognosis].
    Men Y; Hui ZG; Liang J; Feng QF; Chen DF; Zhang HX; Xiao ZF; Zhou ZM; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):682-6. PubMed ID: 27647401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.